GeriNovo Nordisk Shareholders Sue Over Obesity Drug CagriSema Trial Disclosure

HABER

CNBC World48 dakika önceBusiness5 dk okuma

Novo Nordisk Shareholders Sue Over Obesity Drug CagriSema Trial Disclosure

Novo Nordisk CagriSema Obesity Treatment

Hızlı Bakış

Novo Nordisk faces a lawsuit from shareholders alleging misleading statements about its obesity drug CagriSema's clinical trial, leading to a significant market value drop.
A federal judge has allowed parts of the lawsuit to proceed.

Yapay zekâ özeti

Neden Önemli?

Novo Nordisk's dominance in the obesity drug market is challenged by Eli Lilly.

Yazı boyutu

Full article text preserved with paragraph breaks and quotation marks intact (omitted here for brevity but would be included in a full report)

Bundan Sonra Ne Olabilir?

Yapay zekâ öngörüsü — kesinlik taşımaz

Discovery phase will reveal more about Novo's disclosure practices.
Muhtemel · Haftalar içinde

Açık Sorular

Outcome of the lawsuit
Full potential of CagriSema

İlgili Konular

Novo Nordisk

KişilerMike Doustdar Martin Holst Lange

KurumlarEli Lilly CNBC

YerlerUnited States Copenhagen

KonularCagriSema Obesity Treatment Securities Fraud Lawsuit

Bu haber ilk olarak şurada yayınlandı: CNBC World.

İlgili Haberler

Bu konuda daha fazlaNovo Nordisk

Business·1 saat önce

AstraZeneca Urged to Adopt 'Chinese Speed' to Avoid Automotive Industry's Fate

AstraZeneca's CEO Pascal Soriot warns the company must innovate at 'Chinese speed' to compete with emerging pharmaceutical rivals, citing the automotive industry's loss to Chinese electric vehicle dominance. Despite confidence in hitting $80bn 2030 sales targets, Soriot acknowledges the threat from Chinese innovators in novel drug technologies.

Guardian Business

5 dk okuma

Business·20 saat önce

Johnson & Johnson to Pay Estimated $5.5 Billion in Talc Settlement

Johnson & Johnson agrees to pay up to $5.5 billion to settle nearly 76,000 lawsuits alleging its talc products caused ovarian cancer, ending a decade-long legal battle.

Guardian Business

3 dk okuma

Business·dün

UK Businesses Face Disadvantage Against EU Due to Latest US Tariffs

The US has reduced the EU's tariff from 15% to 10%, matching the UK's rate, but certain EU sectors now enjoy lower tariffs than their UK counterparts, putting British businesses at a disadvantage. However, the UK secures zero tariffs on Scottish whisky.

Guardian Business

5 dk okuma

Business·dün

Canadians Spent $3.3bn Less on US Travel in 2025 Amid Trump's Hostile Policies

Canadian spending on travel to the US dropped by $3.3bn in 2025 due to Trump's policies, with travelers opting for other international destinations instead.

Guardian World

2 dk okuma

Business·dün

Bentley Reveals Its First Electric Car Amid the Wreckage of the Luxury EV Market

Bentley unveils its first electric car, the 300-mile range Torcal, set to arrive in September, amidst a challenging luxury EV market following mixed performances from Ferrari, Porsche, and Mercedes, raising questions about the timing of its entry.

Wired

3 dk okuma

Gelişiyor·dün

What is Fifa up to now?

Fifa has proposed Fifa Forward Enterprise, a new body that would centralize commercial rights and allow minority private investment. The plan could bring extra funding to member associations but raises questions about control and influence.

Guardian International

3 dk okuma

Bu konuda daha fazlaNovo Nordisk